EUVIMEDEUVIMED entdecken
Crossref

Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity

Ghada M Suddek, Asmaa E El-Kenawi, Azza Abdel-Aziz, Hassan A El-Kashef

Chemotherapy · 2011 · 57 (4) · 321-326

DOI: 10.1159/000329529 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemotherapy, online erschienen am 01.09.2011. Verfasst von Ghada M Suddek und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Mansoura University, Egypt. ghmsuddek @ yahoo.com. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cisplatin is an effective chemotherapeutic agent successfully used in the treatment of a wide range of tumors. Nevertheless, nephrotoxicity has restricted its clinical use. Recent studies have strongly suggested that inflammatory mechanisms may play an important role in the pathogenesis of cisplatin nephrotoxicity. Celecoxib, a selective cyclooxygenase-2 inhibitor used as anti-inflammatory, may therefore have a protective effect on cisplatin-induced renal injury.

Methods

In the present study, rats were injected intraperitoneally with a single dose of cisplatin (7 mg/kg) and/or celecoxib (30 mg/kg) for 5 days.

Results

Nephrotoxicity manifested biochemically by elevations in serum creatinine, blood urea nitrogen, and proteinuria, and an increase in kidney weight as a percentage of total body weight. In addition, a marked decrease in serum albumin was observed. Lipid peroxidation in the kidney was monitored by measuring the malondialdehyde level and glutathione content, which were increased and depleted, respectively. Administration of celecoxib with cisplatin attenuated cisplatin-induced changes in kidney function parameters and oxidative stress markers. Histopathological examination of the kidney confirmed these results.

Conclusion

In conclusion, this study indicates that celecoxib may be a promising drug for clinical use as a nephroprotectant against cisplatin-induced nephrotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryAnimalsAntineoplastic AgentsBlood Urea NitrogenBody WeightCelecoxibCisplatinCreatinineCyclooxygenase 2 InhibitorsDisease Models, AnimalFemaleKidneyKidney Function TestsMaleMalondialdehydeOrgan SizePyrazolesRatsRats, Sprague-DawleySulfonamides

Substanzen

Antineoplastic AgentsCyclooxygenase 2 InhibitorsPyrazolesSulfonamidesMalondialdehydeCreatinineCelecoxibCisplatin

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Mansoura University, Egypt. ghmsuddek @ yahoo.com

Zitieren

APA

Suddek, G. M., El-Kenawi, A. E., Abdel-Aziz, A., & El-Kashef, H. A. (2011). Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity. Chemotherapy, 57(4), 321-326. https://doi.org/10.1159/000329529

Vancouver

Suddek GM, El-Kenawi AE, Abdel-Aziz A, El-Kashef HA. Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity. Chemotherapy. 2011;57(4):321-326. doi:10.1159/000329529

BibTeX
@article{Suddek2011,
  author = {Suddek, Ghada M and El-Kenawi, Asmaa E and Abdel-Aziz, Azza and El-Kashef, Hassan A},
  title = {Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, Attenuates Renal Injury in a Rat Model of Cisplatin-Induced Nephrotoxicity},
  journal = {Chemotherapy},
  year = {2011},
  volume = {57},
  number = {4},
  pages = {321--326},
  doi = {10.1159/000329529}
}
Kostenlos starten →